Data Foundry

Drug recalls 2026

Biospectra Tris/Tromethamine — Class II drug recall D-0012-2027

Ongoing recall by BioSpectra, Inc., reported 2026-10-14, distributed in CA. Failed stability specifications

Recall numberD-0012-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmBioSpectra, Inc., Bangor, PA, United States
Recall initiated2026-07-29
Classified2026-10-06
Reported by FDA2026-10-14
DistributedCA
Quantity200 kilograms
Reason classesspecification failure
NDC64173-0101-25
Expiration dates2028-02-29

Product

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Reason for recall

Failed stability specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0012-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.